Skip to main content

Home/ MaRS/ Group items tagged Board of Director

Rss Feed Group items tagged

Assunta Krehl

Toronto's $25 million commercialization "engine" celebrates the appointment of its Boar... - 0 views

  • MaRS Innovation is honoured to announce its permanent Board of Directors, who brings together a remarkable and broad set of experiences and networks to support the development of this dynamic partnership of Toronto research institutions.  Designed to enhance the commercial output of Toronto’s world-leading research cluster, MaRS Innovation is positioned to make a significant contribution to Canada’s innovation economy and the quality of life for Canadians and others around the world.
  • upported by the Government of Canada through the Centres of Excellence in Research and Commercialization (CECR) program, and its member institutions, MaRS Innovation is focused on converting important discoveries into a new generation of products, services and high value jobs. The newly appointed Board of Directors, which includes academic and business leaders from across Canada and the United States, has the targeted expertise to guide MaRS Innovation to deliver on this critical mission.   MaRS Innovation represents a unique collaborative model, which aggregates the exceptional discovery pipeline of 14 leading Toronto academic institutions to build a diversified portfolio of assets, and harness the economic and job creation potential of the best opportunities for Toronto, Ontario and Canada.
  • “MaRS Innovation is privileged to announce a Board of Directors of this caliber and breadth of skill,” said Mary Jo Haddad, Chair of the MaRS Innovation Board and President and CEO of The Hospital for Sick Children. “The collective experience and guidance of these individuals will be critical to developing a collaborative, integrated and agile approach to this transformational organization that will move Canada into its next phase of economic development.”
  • ...2 more annotations...
  • W. Geoffrey Beattie – Deputy Chairman & President, Woodbridge Company Limited, Thomson Reuters Corporation, Toronto Christopher C. Capelli – Vice President, Technology Based Ventures, Office of Technology Commercialization, University of Texas, M.D. Anderson Cancer Center, Houston, TX Ron Close – Information technology entrepreneur, Entrepreneur-in-Residence, MaRS, and Executive Entrepreneur-in-Residence, The Richard Ivey School of Business, The University of Western Ontario, London, ON Nicholas Darby – Formerly Director of Physical Sciences, Corporate Venture Capital, Dow Chemical Company, President, Darby & Associates Consulting LLC, Midland, MI  Mary Jo Haddad – President & CEO, The Hospital for Sick Children, Toronto Jacqueline H.R. Le Saux – Former General Counsel, North America and Corporate Secretary, Patheon, Inc., Toronto David A. Leslie - Chair, Sunnybrook Health Sciences Centre, and Former Chairman & CEO, Ernst & Young, Toronto Michael H. May – President & CEO, Rimon Therapeutics, Toronto Chandra J. Panchal – Founder, President & CEO, Axcelon Biopolymers Corp., Dollard-des-Ormeaux, QC Ilse Treurnicht – CEO, MaRS Discovery District, Toronto Donald A. Wright – President & CEO, The Winnington Capital Group Inc., Toronto
  • MaRS Innovation serves as a business accelerator platform with a single point of entry for industry partners and investors.  It will increase the scale, scope and viability of IP offerings, and the quantity and quality of deal flow from partner institutions.  MaRS Innovation will also facilitate strategic research collaborations with industry partners, strengthen the innovation capacity of Canadian industry through adoption of new technologies from its member institutions, and launch a new generation of robust, high-growth Canadian companies that will become global market leaders.   The quality of the combined discovery pipeline will catalyze and attract sources of risk capital for translational research, market validation, company formation and growth.  “MaRS Innovation represents a unique and timely platform to contribute in a meaningful way to Canada’s knowledge economy, leveraging Toronto’s remarkable research excellence.  The vision and serious commitment of its members to work together to transform our commercialization results, and the support of the Federal Government, made this possible.  The announcement of this outstanding group of leaders to the Board of Directors for MaRS Innovation is an exciting step forward,” said Ilse Treurnicht, MaRS CEO and interim Managing Director of MaRS Innovation.
  •  
    MaRS Innovation announced its permanent Board of Directors. MaRS Innovation is focused on converting important discoveries into a new generation of products, services and high value jobs.
  •  
    MaRS Innovation announced its permanent Board of Directors. MaRS Innovation is focused on converting important discoveries into a new generation of products, services and high value jobs. Feb 6, 2009
Assunta Krehl

Dr. Calvin Stiller appointed Chair of Board of Directors - Ontario Institute for Cancer... - 0 views

  • The Board of Directors of the Ontario Institute for Cancer Research (OICR) has appointed Dr. Calvin Stiller as the Chair of the Board.
  • He succeeds Dr. John Evans, who was the first Chair and who will continue to serve as a board member.
  • Dr. Stiller co-founded the MaRS Centre in Toronto
  •  
    The Board of Directors of the Ontario Institute for Cancer Research (OICR) has appointed Dr. Calvin Stiller as the Chair of the Board. Mention of Dr. Stiller Co-Founding MaRS.
  •  
    The Board of Directors of the Ontario Institute for Cancer Research (OICR) has appointed Dr. Calvin Stiller as the Chair of the Board. Mention of Dr. Stiller Co-Founding MaRS. Jan 21, 2009
Assunta Krehl

CNW Group | MARS DISCOVERY DISTRICT | Michael H. McCain joins MaRS Board, Founder Dr. J... - 0 views

  • MaRS Discovery District is pleased to announce the appointment of Michael H. McCain, President and CEO of Maple Leaf Foods Inc., to its Board of Directors.
  • Mr. McCain is looking forward to joining the MaRS Board of Directors as wel
  • Mr. McCain
  • ...3 more annotations...
  • inaugural Fundraising Cabinet, chaired by Hon. John Manley. "I am deeply impressed by the vision of MaRS, and its resolve to bring forth the talents of Canadians in order to build better companies," Mr. McCain said. "MaRS is well-positioned to contribute
  • Mr. McCain
  • o the Canadian economy and is an important player in the development of new, innovative businesses. MaRS can also help bring innovation into existing companies, thus making them more competitive globally."
  •  
    MaRS Discovery District announces the appointment of Michael H. McCain, President and CEO of Maple Leaf Foods Inc., to its Board of Directors.
Assunta Krehl

ARISE Technologies Announces Appointment of New Chairman and Changes to Senior Manageme... - 0 views

  •  
    RISE Technologies Corporation, a leader in high-performance, high-quality, cost-effective solar technology, today announced the appointment of Mr. Peter Harder as Chairman of the Company's Board of Directors. Mention of William White being on the Board of Directors for MaRS Discovery District. Nov 11, 2009
Assunta Krehl

Business newsmaker - The Star - 0 views

  • MARS DISOVERY DISTRICT has appointed businessman and philanthropist Richard Ivey to its board of directors.
  • "Richard Ivey has a strong track record of community involvement and commitment to research and innovation, most recently through his continuing role as chair of the Canadian Institute for Advanced Research," said John Evans, founding chair of the board at MaRS. "His integrity and dedication to building a strong foundation for Canada's innovation economy will be of tremendous benefit to MaRS"
  • MaRS is a Toronto non-profit centre linking science, technology and social entrepreneurs with business skills and capital to stimulate innovation and the creation of successful Canadian companies.
  •  
    MARS DISOVERY DISTRICT has appointed businessman and philanthropist Richard Ivey to its board of directors.
  •  
    MaRS Discovery District has appointed businessman and philanthropist Richard Ivey to its board of directors. Feb 20, 2009
Assunta Krehl

The Centre for Commercialization of Regenerative Medicine (CCRM): CCRM Announces Its In... - 0 views

  •  
    Rafi Hofstein, President and CEO of MaRS Innovation is one of the inaugural Board of Directors for The Centre for Commercialization of Regenerative Medicine (CCRM). CCRM is a MaRS tenant.
Assunta Krehl

MEDEC appoints Peter Robertson as Chair of the MEDEC Board of Directors - Digital Journ... - 0 views

  •  
    "Peter Robertson as Chair of the MEDEC Board of Directors. Peter Robertson is Vice President and General Manager of GE Healthcare Canada. Peter is also a member of the management board for MaRS' Excellence in Clinical Innovation and Technology Evaluation (""EXCITE"") program."
Sarah Hickman

MaRS Discovery District - Recommended Resources - Entrepreneurship Resources - Stonewoo... - 0 views

  •  
    While governance and fiduciary matters command a bigger share of their time and attention, the hiring of CEOs is among the most important, value-added responsibilities of Boards of Directors. It is also one exercised ever more frequently, with statistics showing that two-thirds of all venture-backed startup companies replace their founding CEOs and of these replacements, two out of every five fail in the first 18 months.
Assunta Krehl

Announcement - Canada's Outstanding CEO of the Year? Award Program 2009 - National Post - 0 views

  • The Caldwell Partners, Deloitte and National Post are pleased to announce the appointment of Gordon M. Nixon to Canada's Outstanding CEO of theYearTM Advisory Board for 2009.
  • Mr. Nixon is Chairman of the Canadian Council of Chief Executives, Chairman of MaRS Discovery District, and is on the Board of Directors of The Hospital for Sick Children, The International Monetary Conference, Catalyst Canada and is on the Advisory Board of Mercedes-Benz Canada.
  •  
    Announcement regarding the appointment of Gordon M. Nixon to Canada's Outstanding CEO of theYearTM Advisory Board for 2009. Sept 2, 2009
Assunta Krehl

Richard W. Ivey joins Board of Directors at MaRS - Canada Newswire - 0 views

  •  
    MaRS Discovery District has appointed businessman and philanthropist Richard Ivey to its board of directors. Feb 19, 2009
Assunta Krehl

Look who just landed on MaRS - The Globe and Mail - 0 views

  • Look who just landed on MaRS
  • MaRS was known for just that – putting a collective roof over the heads of Canada's out-of-this-universe thinkers. Aside from hosting the unlikely duo of Arnold Schwarzenegger and Dalton McGuinty at a funding announcement two years ago, the centre seems enveloped in galactic silence.
  • corner of College and University
  • ...12 more annotations...
  • the country's most significant collection of scientific and medical researchers.
  • This week, a program called MaRS Innovation announced the appointment of its first full-time president, Raphael (Rafi) Hofstein, a Harvard-trained, Israeli biomedical wizard who wants to bring together companies, scientists and funding under one roof to create a special alchemy of science and shekels.
  • Since its inception, MaRS has focused on turning big ideas into commercial projects. The difference between the two entities is that pretty much anyone with an idea or discovery could come to MaRS for support, regardless of whether they had their “eureka” moment in a state-of-the-art research lab or in their garage. MaRS Innovation, a separate endeavour with its own board of directors, only works with researchers from its 14 partner institutions, which include some of the most prestigious universities and hospitals in Canada. The goal of that project is to do the kind of work those institutions would normally try to do in-house, but on a bigger scale and, the project's backers hope, with better results.
  • MaRS Innovation is very much in its infancy. Officially launched last June, the project is barely a year old, and the board of directors was only announced this February. It has secured about $25-million in funding over five years to be used for commercialization of projects.
  • Dr. Hofstein is giving himself two to three years to roll out a success story – be it the creation of a new small company founded on the back of a researcher's drug discovery and funded by a big pharmaceutical firm, or a new discovery that, packaged properly, attracts serious venture-capital money.
  • The federal government has also taken notice, naming MaRS Innovation as one of 11 new “Centres of Excellence for Commercialization and Research,” a designation that came with almost $15-million in funding.
  • California Governor Arnold Schwarzenegger speaks at MaRs with Premier Dalton McGuinty after a tour of the building in 2007.
  • Indeed, the MaRS Innovation model of pushing for commercial applications of research seems to be directly in line with the philosophy of the Conservative government, which clearly favours practical results when it comes to funding for scientific research.
  • But those tasks involve two separate skill sets, Mr. Tabrizi suggests, and may be much better suited to a place such as MaRS, where academic and industry heavyweights converge.
  • Many of MaRS's biggest partners are in health care, and Dr. Hofstein is jumping in with a list of priorities that includes focusing on stem-cell research and oncology.
  • MaRS itself has always been good at bringing people from various sectors together, but there's no guarantee that Dr. Hofstein's plan will work, especially in the two-to-three-year timeline he mentions when talking about a rollout date for the first MaRS Innovation projects.
  • Indeed, Mr. Tabrizi says some Silicon Valley insiders marvel at what MaRS Innovation is trying to do. “I think there's something innovative there,” he says. “Something different is being done.”
  •  
    MaRS Innovation announced the appointment of its first full-time president, Raphael (Rafi) Hofstein.
Assunta Krehl

Semcan Announces the Appointment of Robert Tweedy to the Board of Directors - Melodika ... - 0 views

  •  
    Robert Tweedy a MaRS Advisor has been appointed to the board of directors of Semcan.
Sarah Hickman

MaRS Discovery District - Recommended Resources - Global Market Reports - VHA Research ... - 0 views

  •  
    "The United States spends more on health care-related research and development than any other country. In 2003, it was estimated that the Federal government alone spent over $26 billion. Pharmaceutical companies, device manufacturers and other private companies invested over $10 billion more. At its best, the American health care system is capable of delivering care unsurpassed anywhere else in the world. Yet, a 1999 Institute of Medicine study estimated that as many as 98,000 Americans die each year from hospital related medical errors. A recent study by the Rand Corporation (a non-profit think tank) concluded that less than 50 percent of encounters with doctors and hospitals resulted in optimal, evidence-based treatment. Studies show that as many as 42 million Americans - almost 15 percent of the population - lack health care insurance. Surveys reveal that patients do not feel they have adequate information about their conditions, and that their experience with health care ranks below that of most other sectors, in fact below that of the post office. In the aggregate, the country is spending nearly $2 trillion on health care, and yet the nation's health care system does not meet acceptable thresholds for safety, quality, access or cost. In 2005, VHA Health Foundation's board of directors sought to better understand the reasons behind this paradox. The foundation commissioned Larry Keeley and his associates at Doblin Inc. to apply the rigorous analytical methods that are used in their evaluation of other American industries and companies. The project set out to discover when, where and how innovation was taking place in health care. It also sought to identify organizations that were developing model innovation processes, and to explore where opportunities for successful innovation might lay."
Cathy Bogaart

Voting for Innovation « Blog by Earl Miller | Vote Toronto 2010 - 0 views

  •  
    Earl Miller, Director, Strategic Partnerships at MaRS, writes on the Toronto Board of Trade about the upcoming mayoral debate at MaRS. In the aftermath of a global financial crisis, cities are looking for ways to generate growth. Find out how the mayoral candidates will support that growth at the September 8th debate at MaRS.
Assunta Krehl

Pershing Square Announces Another Prominent Canadian Business Leader to Join the Nomine... - 0 views

  •  
    Pershing Square Capital Management, L.P. announced that Paul Haggis, one of Canada's most respected business leaders, has agreed to join the Nominees for Management Change. Dr. Anthony R. Melman, 64, is Chairman and Chief Executive Officer of Nevele Inc. Dr Melman is also the Chair of the Board of Directors Dr. Melman pf Cogniciti Inc., a for-profit joint venture created by Baycrest and MaRS Discovery District.
Assunta Krehl

Scratching The Biotech Surface - Backbone Magazine - 0 views

  • We don’t know for sure,” said Dr. John Evans, chair of the board of directors at MARS (Medical and Related Sciences) Discovery District in Toronto, and vicechair of Mississauga, Ont.-based NPSAllelix Biopharmaceuticals, one of the pioneers of biotech in Canada. “But we believe that if you could ‘type’ the patient processes of how he/she handles a drug, you could peel off those people who would be particularly sensitive to a drug. Then you could find a sub-population where the drug is safe and highly effective.” Evans used the arthritis drug Vioxx as an example. It helped millions of people battle painful inflammation, but was pulled from the market recently because of potential cardiac side effects in some people. “If the drug company could have predicted which patients would have complications from Vioxx treatment — through some genetic profiling — then a very powerful and effective drug could have been preserved,” Evans said. His company, NPS-Allelix Bio-pharmaceuticals, has been developing a product since 1989 that will be launched later this year. The drug secretes a parathyroid hormone for treating osteoporosis.
  • It builds up bone matrix and helps build bone, rather than just delay bone loss as other drugs do.
  •  
    The field of biotechnology is a collaboration between research disciplines who have a quantitative view of the world. A review of how human genome affects drug development is reviewed.
  •  
    The field of biotechnology is a collaboration between research disciplines who have a quantitative view of the world. A review of how human genome affects drug development is reviewed. Sept 11, 2005
Assunta Krehl

Ontarians honoured for achievement - National Post - January 26, 2010 - 1 views

  •  
    Paul Godfrey, president and CEO of the National Post, War Child Canada founder Dr. Samantha Nutt, and businessman Lawrence Bloomberg topped the list of 29 Canadians named to the Order of Ontario yesterday. Lawrence Bloomberg is also a Founder and Director of MaRS.
Assunta Krehl

Two women from MaRS - Entrepreneur - Financial Post - May 22, 2012 - 0 views

  •  
    MaRS Discovery District has earned global recognition as a hub of innovation for technology and clean-tech startups since its launch in 2005. Mary Teresa Bitti, Financial Post reporter interviews Dr. Ilse Treurnicht, CEO, MaRS Discovery District and Allyson Hewitt, Director, Social Entrepreneurship,  SiG@MaRS about social innovation.
Cathy Bogaart

Entrepreneurs doing good | Saving the world | The Economist - 0 views

  • The temple has a conference room equipped with state-of-the-art audio-visual aids. Its board of directors includes several leading software billionaires and their wives, providing it with money as well as connections.
  • The monks are entrepreneurs as well as holy men, one moment talking about reincarnation and the next about sustainable delivery models.
  • he temple provides 200,000 local schoolchildren with free meals every day.
  • ...3 more annotations...
  • purpose of feeding India’s rural poor. He invested $1m—and many years of his life—in breeding a superchicken
  • invented a “lapdesk” that sits on the child’s lap and provides a stable surface. The desks are covered in advertisements, so Mr Immelman is able to hand them out free,
  • In the long run, however, the best thing that entrepreneurs can do for the poor may be simply to see them as workers and customers.
  •  
    The Economist shows how different entrepreneurs around the world are creating businesses with the goal of improving the world, while still making money: social entreprenuership
Assunta Krehl

MaRS' Net Change Week: Social experiment and huge success - 0 views

  • Between June 8-12, 2009, MaRS held our first ever Net Change, a week dedicated to exploring this intersection between social technology and social change.
  • Fourteen different Net Change events, including an art show, experimented with ways of creating and sharing information and knowledge on this question. Bridging the “digital divide” between web professionals and people creating social change, participants were from all different sectors and leadership levels. T
  • Net Change also addressed critical concepts such as how to measure the impact of social technology, and what we really mean by social change, while including storytelling to hit theoretical concepts home.
  • ...7 more annotations...
  • Web 2.0 training sessions for organizations, non-profits and social purpose ventures Conversations with keynotes and panel discussions hosted by community partners like Mobile Monday @MaRS, Toronto Net Tuesday and Wired Wednesday Immersion sessions that “prepare your mind” for innovative thought
  • Net Change story
  • Net Change video message from Don Tapscott:
  • “The Skills Exchange”:
  • profound innovation and social change
  • Bill White, a member of MaRS’ Board of Directors at our evening “Fireside Chat”
  • Net Change Art Show:
  •  
    Net Change, a week dedicated to exploring this intersection between social technology and social change. Lisa Torjman's interview with CP24's "Homepage."
1 - 20 of 23 Next ›
Showing 20 items per page